Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Epilepsy Currents|February 28, 2012
Generic antiepileptic drugs: how good is close enough?Barry E Gidal
Epilepsy Research|January 18, 2006
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugsBarry E Gidal
Epilepsy Currents|June 19, 2014
P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?Barry E Gidal
Epilepsy Currents|August 29, 2015
Phenytoin Hypersensitivity: It's Time for Some IndividualityBarry E Gidal
Epilepsia|August 23, 2022
Rescue therapies for seizure clusters: Pharmacology and target of treatmentsBarry Gidal, Kamil Detyniecki
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Risk Factors Associated With Multidrug-Resistant Pneumonia in Nonhospitalized PatientsAlex Gidal, Susanne Barnett
Journal of the American Pharmacists Association : Japha|July 11, 2015
Pediatric seizures and vaccinesLuiza Kerstenetzky, Barry Gidal
Stroke|September 30, 2005
Phenytoin and cognitive declineSebastian Koch, Barry E Gidal
Epilepsia|December 18, 2008
Debate: Substitution of generic drugs in epilepsy: is there cause for concern?Barry E Gidal, Torbjörn Tomson
CNS Spectrums|July 28, 2006
Sexual dysfunction in patients with neuropsychiatric disorders: Challenges and opportunitiesBarry Gidal, John J Barry
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Epilepsy Currents|February 28, 2012
Generic antiepileptic drugs: how good is close enough?Barry E Gidal
Epilepsy Research|January 18, 2006
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugsBarry E Gidal
Epilepsy Currents|June 19, 2014
P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?Barry E Gidal
Epilepsy Currents|August 29, 2015
Phenytoin Hypersensitivity: It's Time for Some IndividualityBarry E Gidal
Epilepsia|August 23, 2022
Rescue therapies for seizure clusters: Pharmacology and target of treatmentsBarry Gidal, Kamil Detyniecki
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Risk Factors Associated With Multidrug-Resistant Pneumonia in Nonhospitalized PatientsAlex Gidal, Susanne Barnett
Journal of the American Pharmacists Association : Japha|July 11, 2015
Pediatric seizures and vaccinesLuiza Kerstenetzky, Barry Gidal
Stroke|September 30, 2005
Phenytoin and cognitive declineSebastian Koch, Barry E Gidal
Epilepsia|December 18, 2008
Debate: Substitution of generic drugs in epilepsy: is there cause for concern?Barry E Gidal, Torbjörn Tomson
CNS Spectrums|July 28, 2006
Sexual dysfunction in patients with neuropsychiatric disorders: Challenges and opportunitiesBarry Gidal, John J Barry
Pageof 28